(Q82732869)
Statements
Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects (English)
Wendy G Halpern
Patrick Lappin
Thomas Zanardi
Wendy Cai
Marta Corcoran
John Zhong